Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

The Ozone Man Treats Xaverian High School To Prevent Spread Of Contaminated Swine Flu Within Its Indoor Environments
The Ozone Man, Inc. (OTCBB: OZOM), dba TOMI Environmental Solutions, or TOMIES, announced today the completion of a deep cleaning treatment of Xaverian High School with a student body of 1400 located in Brooklyn, New York. The Ozone Man"s treatment eliminated contaminants including Swine Flu "H1N1" along with inactivating viruses. The Ozone Man"s treatment also eliminates odor, mold spores and kills bacteria in the treated areas. Its proprietary Ultraviolet Ozone Generators produce the cleanest ozone south of the stratosphere, helping to ensure the health, safety and well being of the building and its inhabitants.
generic viagra online
British Researchers Call For WHO To 'Condemn Homeopathy' For Serious Diseases
British researchers on Monday requested the WHO "publicly condemn homeopathy as a treatment for serious diseases, such as HIV/AIDS, TB and malaria," amid growing concern that some patients are dying as a result of choosing homeopathy over effective medicines, the Mail & Guardian reports. "The WHO works with national organisations that promote homeopathy and other alternative medicines in their public health programmes," according to the Mail & Guardian.
News of the day
Reich: Obama Must Increase Pressure To Reform Health Care
NPR interviewed Robert Reich, professor of public policy at the University of California at Berkeley and former Secretary of Labor in the Clinton administration, on the steps President Barack Obama needs to take to successfully reform health care. Recently, Reich sent Obama a memo "outlining six things the president must to do save universal health care." Reich told NPR that "health care is stalling in the Senate," and Obama must "fire people up" and "be tough" to counter the medical industry, which has "some of the most formidable lobbies in the country." Reich said that Obama is only going to succeed if he "counts noses, cajoles, twists arms, threatens - and I think he does have it in him." He adds that while "bipartisanship is a noble aspiration," "we"re getting to the point where the president has got to say if I do not get your votes on this, Republicans, I"m going to go through reconciliation. I"m going to do it without you" (Martin, 6/29).
Nutrition

New Treatments Should Be Introduced Gradually To Avoid Later Problems, Says Expert

Concerns over whether the tests a treatment undergoes before release onto the market are enough to ensure its long-term safety are raised in an editorial published by BMJ Clinical Evidence today. Dr Vijay Sharma suggests that treatments should be introduced gradually so that evidence can be built up and the treatment can find its proper niche. To illustrate this, he discusses the recent debate on the long-term safety of drug-eluting stents. Stents (small tubes) are used to unblock arteries that have become thickened by fatty deposits. They improve blood flow and reduce the risk of death from coronary artery disease. Drug-eluting stents slowly release drugs to stop blood clots blocking the stented arteries, a process called restenosis. Drug-eluting stents were used with great enthusiasm when first introduced in 2002, but since 2006 several reports have highlighted an increased risk of clotting as late as one year after treatment (known as late-stent thrombosis). But why was this risk not detected sooner, asks the author? One reason may relate to the outcomes that early clinical trials set out to measure. Another may be that trials have predominantly focused on low risk cases, yet drug-eluting stents were also used in complex cases, where the underlying risk of clotting is higher. More complex cases also require the use of more stents and longer stents, further increasing the risk of late-stent thrombosis, he explains. All adverse effects must be carefully assessed in large-scale studies, writes Dr Sharma. But they must also be balanced against the threat posed by coronary artery disease itself, and interpreted in the context of other treatment options. He concludes: "Treatments are often greeted with enthusiasm when they first appear only to fall into disfavour when adverse effects are found. Then, with time, some of these treatments return with a more limited and clearly defined use. To avoid this pattern, adverse effects should be actively sought, and treatments should be introduced gradually so that experience and evidence can be built up and the treatment can find its proper niche." British Medical Journal


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009